Status:
UNKNOWN
Immunological Characteristics of COVID-19 Patients
Lead Sponsor:
The University Clinic of Pulmonary and Allergic Diseases Golnik
Collaborating Sponsors:
National Institute of Chemistry, Slovenia
Conditions:
Covid19
Eligibility:
All Genders
18+ years
Brief Summary
The study will look at the immunological characteristics of COVID-19 patients and determine neutralizing antibodies against SARS-CoV-2 virus.
Detailed Description
The immunogram (quantitative TBNK immunophenotipisation) will be performed by flow cytometry, the antibody response will be determined by IVD ELISa. Clinical biochemical and immunochemical (ECLIA) te...
Eligibility Criteria
Inclusion
- Provide written consent before being included in the essay.
- Positive cases of COVID-19 (based on polymerase chain reaction or positive antigen test for SARS-CoV-2).
Exclusion
- Patients who are unable to give consent or who are unable to follow up will be excluded.
Key Trial Info
Start Date :
May 7 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 7 2023
Estimated Enrollment :
230 Patients enrolled
Trial Details
Trial ID
NCT04679428
Start Date
May 7 2020
End Date
May 7 2023
Last Update
December 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Clinic of Respiratory and Allergic Diseases Golnik
Golnik, Slovenia, 4204